Pharmapacks has raised a total of $322 million in funding across multiple rounds, including a major $250 million Series D round in November 2020, which increased its valuation to $1.1 billion. Earlier rounds include a $40 million Series C and an undisclosed Series B backed by GPI Capital and JPMorgan Chase. Founded in 2011, Pharmapacks became a unicorn in under ten years by scaling its e-commerce platform for pharmaceuticals, beauty, and daily essentials. Strong investor participation from Carlyle Group, RB, and The Craftory fueled its rapid growth.